---
title: TECregen
date: 2026-01-08T08:00:15Z
modified: 2026-08-12T08:56:18Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/tecregen/"
type: portfolio
status: publish
excerpt: ""
wpid: 128038
language:
  - English
post_translations:
  - pll_695e65fa5e6a0
branchen22:
  - Rejuvenation
sectors:
  - Pharmaceuticals
focus_areas:
  - Rejuventation
timestamp: 2026-08-12T08:56:18Z
tags:
  - English
  - pll_695e65fa5e6a0
  - Rejuvenation
  - Pharmaceuticals
  - Rejuventation
---

## Beschreibungstext

TECregen is pioneering thymus rejuvenation to address conditions driven by impaired T-cell responses. The company’s innovative approach focuses on revitalizing and expanding thymic epithelial cells (TECs) to replenish T cells and achieve durable improvements in immune function. By developing a pipeline of differentiated thymopoietic biologics, TECregen aims to strengthen immune recovery following transplantation or cytotoxic therapy, promote immune health, and enhance immune surveillance against cancer, ushering in a new era of immunotherapy.

## Unternehmenswebsite

https://www.tecregen.com/

## Adresse

Stücki Technologie Park Basel
Hochbergerstrasse 60C
4057 Basel
Switzerland